Khalid Mohamedali, Ph.D.
Department of Experimental Therapeutics, Division of Cancer Medicine
Grant & Contract Support
| Title: | Targeting EMP2 on ovarian cancer cells with an immune-oncology agent to circumvent drug resistance or recurrent disease |
| Funding Source: | Rivkin Center for Ovarian Cancer |
| Role: | Principal Investigator |